Brief Assessment of Parents' Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS)
Beth N. Peshkin(Georgetown University), K. P. Tercyak(Dana-Farber Cancer Institute), Andrea Farkas Patenaude(Harvard University), Tiffani A. DeMarco(Georgetown University), Mark D. Schwartz(New York University), J. E. Garber(Beth Israel Deaconess Medical Center), Heiðdís Valdimarsdóttir(Reykjavík University), Katherine A. Schneider(Dana-Farber Cancer Institute)
Cited by 37
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
Psychosocial Functioning in Pediatric Cancer
|Journal of Pediatric Psychology|2004|414
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Impact of <i>BRCA1</i>/<i>BRCA2</i> Counseling and Testing on Newly Diagnosed Breast Cancer Patients
|Journal of Clinical Oncology|2004|250